Aniridia is an eye disorder that affects the iris (the coloured part of the eye responsible for controlling the amount of light entering your eye). The iris is either partially formed or completely absent, leading to vision problems and light sensitivity. Although uncommon, this condition requires careful management to help eyesight and reduce risk of associated problems. Let’s learn all that’s there to know about this iris abnormality.
What is aniridia?
Aniridia is a rare eye condition where the iris fails to develop fully. The absence of part or complete iris not only changes the eye appearance but can also lead to light sensitivity, reduced vision and increased risk of other eye problems. Aniridia is a congenital eye disorder that occurs from birth and usually affects both eyes. It is linked to a genetic change, often involving the PAX6 gene.
Symptoms and signs of aniridia
The symptoms and signs of aniridia can vary from person to person but often include:
- Light sensitivity (photophobia) due to reduced control over light entering the eye
- Blurry vision or reduced visual clarity
- Nystagmus: involuntary eye movements
- Glaucoma: increased eye pressure
- Cataracts: clouding of the eye’s lens
- Reduced visual field
In children, early signs may include unusual eye movements, trouble focusing or squinting in bright light.
Causes and risk factors
- Genetic mutation: Most congenital cases are linked to a mutation in the PAX6 gene.
- Family history: Aniridia can be inherited in an autosomal dominant pattern, meaning a parent with the condition has a 50% chance of passing it on. Rare autosomal recessive forms also exist.
- Associated syndromes: In some cases, it occurs alongside other health conditions, such as WAGR syndrome (Wilms tumour, Aniridia, Genitourinary anomalies and Range of developmental delays).
Diagnosis of aniridia eye disorder
Early diagnosis is key to promote vision health and manage associated eye conditions. An experienced ophthalmologist can diagnose aniridia by:
- Checking the iris structure, eye pressure and retina health with a comprehensive eye examination.
- Genetic testing to confirm inherited forms and assess risk to family members.
- Screening a child’s vision for early detection, especially in newborns from affected families.
Treatment for aniridia
Alastair Lockwood, experienced optician at Feel Good Contacts explains that “There is currently no proven cure for aniridia, but treatment for aniridia focuses on improving vision and protecting eye health. Aniridia patients need regular monitoring to keep a track of potential vision changes. If they develop associated conditions such as glaucoma or cataracts, surgery may be required.”
Living with aniridia eye disorder
While aniridia is a lifelong condition, there are ways to protect vision and maintain quality of life:
- Eye protection: Glasses with tinted or photochromic lenses or sunglasses can help manage light sensitivity.
- Vision aids: Magnifiers, large-print materials and adaptive technology can make daily life easier.
- Genetic counselling: Helpful for families to understand inheritance patterns and future risks.
- Support groups: Connecting with others can provide emotional support and practical advice.
- Routine eye care: Lubricating eye drops can help relieve dryness and protect the cornea.
- Regular check-ups: Essential to monitor for glaucoma, cataracts or corneal issues.
FAQs
What is aniridia eye disorder?
Aniridia is a rare condition where the iris is partially or completely missing, affecting vision and light control.
Can aniridia be cured?
There is no cure, but treatment for aniridia can help manage symptoms and protect vision.
Is aniridia hereditary?
Yes, most cases are inherited in an autosomal dominant pattern, though some can occur without a family history.
What vision problems are associated with aniridia?
People with aniridia may experience light sensitivity, reduced vision, glaucoma, cataracts and nystagmus.
Dr Alastair Lockwood is an experienced ophthalmologist and eye health advisor. The major focus of his career is on preventing sight loss caused by glaucoma and other serious eye conditions. Along with undergraduate training at Cambridge University and clinical training at Oxford University, Alastair has also completed an MRC-funded PhD at the UCL Institute of Ophthalmology and Moorfields Eye Hospital. Dr. Alastair combines surgical expertise with a passion for research, regularly advising his patients on various eye care concerns and prescribing dry eye treatments and eye care products.
